Alpha Cognition (ACOG) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Whitehawk Therapeutics (WHWK) has outperformed Alpha Cognition (ACOG) over the past year, gaining 62.9% versus a gain of 17.1%. Alpha Cognition is the larger company by market cap ($197.7 million vs $197.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACOG | WHWK |
|---|---|---|
| Share price | $9.08 | $3.46 |
| Market cap | $197.74M | $197.25M |
| 1-day change | +0.44% | -0.29% |
| YTD return | +39.08% | +43.39% |
| 1-year return | +17.10% | +62.91% |
| 5-year return | — | -87.25% |
| EPS (TTM) | $-1.32 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.14 | $5.50 |
| 52-week low | $4.50 | $1.87 |
| Distance from 52-week high | -10.45% | -37.03% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +98.24% | +122.83% |
| Average volume | 125.72K | 367.72K |
| Shares outstanding | 21.78M | 57.01M |
| Employees | 71 | 32 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WHWK has outperformed ACOG by 45.8 percentage points over the past year.
- The two companies sit in different sectors: Alpha Cognition in Healthcare and Whitehawk Therapeutics in Health Care.
About Alpha Cognition
ACOG stock →Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
Healthcare · Biotechnology · 71 employees
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
ACOG vs WHWK FAQ
Which is bigger, Alpha Cognition or Whitehawk Therapeutics?
Alpha Cognition (ACOG) is larger, with a market capitalization of $197.74M compared with $197.25M for Whitehawk Therapeutics (WHWK).
Which stock has performed better over the past year, ACOG or WHWK?
WHWK returned +62.91% over the past 12 months, compared with +17.10% for ACOG (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Cognition and Whitehawk Therapeutics in the same industry?
No. Alpha Cognition is in the Healthcare sector, while Whitehawk Therapeutics is in Health Care.